Home
>
National Drug Code (NDC)
>
Carisoprodol and Aspirin
Carisoprodol and Aspirin - 23155-145-01 - (Carisoprodol and Aspirin)
Drug Information of Carisoprodol and Aspirin
| Product NDC: | 23155-145 |
| Proprietary Name: | Carisoprodol and Aspirin |
| Non Proprietary Name: | Carisoprodol and Aspirin |
| Active Ingredient(s): | 325; 200 mg/1; mg/1 & nbsp; Carisoprodol and Aspirin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Carisoprodol and Aspirin
| Product NDC: | 23155-145 |
| Labeler Name: | Heritage Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089594 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110331 |
Package Information of Carisoprodol and Aspirin
| Package NDC: | 23155-145-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (23155-145-01) |
NDC Information of Carisoprodol and Aspirin
| NDC Code | 23155-145-01 |
| Proprietary Name | Carisoprodol and Aspirin |
| Package Description | 100 TABLET in 1 BOTTLE (23155-145-01) |
| Product NDC | 23155-145 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carisoprodol and Aspirin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110331 |
| Marketing Category Name | ANDA |
| Labeler Name | Heritage Pharmaceuticals Inc. |
| Substance Name | ASPIRIN; CARISOPRODOL |
| Strength Number | 325; 200 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
